+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Age Related Vision Dysfunction Drug"

Age-related Vision Dysfunction - Epidemiology Forecast to 2032 - Product Thumbnail Image

Age-related Vision Dysfunction - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Age Related Vision Dysfunction Drug market is a subset of the Optical Disorders Drugs market, which focuses on treatments for vision-related issues. These drugs are used to treat age-related vision problems such as macular degeneration, cataracts, and glaucoma. They are designed to improve vision, reduce pain, and slow the progression of the disease. Common treatments include eye drops, injections, and laser treatments. The Age Related Vision Dysfunction Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Allergan, Novartis, Pfizer, and Regeneron. Other companies such as Bausch Health, Santen Pharmaceuticals, and Valeant Pharmaceuticals also offer treatments for age-related vision problems. Show Less Read more